Supportive Care Mobile Application for Patients With NSCLC
This research study is looking at the role of a supportive care mobile app in improving symptoms, coping skills, and quality of life in patients with non-small cell lung cancer.
Checked against the public recordLast updated Nov 22, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Behavioral: Supportive Care Mobile Application; Other: Usual Care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age \>18 years * Diagnosed with unresectable Stage III or IV NSCLC in the past twelve weeks and receiving care with palliative intent (per clinician documentation in the electronic health record) * Eastern Cooperative Oncology Group Performance Status = 0-3 * Plan to receive oncology care at one of the participating study sites * Ability to read and respond to questions in English Exclusion Criteria: * Significant uncontrolled psychiatric disorder (e.g., psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the ability to participate in study procedures
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Massachusetts General Hospital Cancer CenterBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Mass General/North Shore Cancer CenterDanvers, Massachusetts
- Dana-Farber Brigham Cancer Center at Milford Regional Medical CenterMilford, Massachusetts
- Newton-Wellesley HospitalNewton, Massachusetts
- Dana-Farber Brigham Cancer Center at South ShoreSouth Weymouth, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 22, 2024. Always confirm current availability with the study team.